Picture of Seer logo

SEER Seer Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-9.24%
3m+0.68%
6m-22.57%
1yr-62.46%
Volume Change (%)
10d/3m+16.68%
Price vs... (%)
52w High-70.62%
50d MA-7.83%
200d MA-27.5%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-24.46%
Return on Equity-20.45%
Operating Margin-620.99%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Seer EPS forecast chart

Profile Summary

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
March 16th, 2017
Public Since
December 4th, 2020
No. of Shareholders
32
No. of Employees
147
Sector
Office Equipment
Industry
Technology
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
64,773,180

SEER Share Price Performance

Upcoming Events for SEER

Q1 2024 Seer Inc Earnings Release

Seer Inc Annual Shareholders Meeting

Q2 2024 Seer Inc Earnings Release

Similar to SEER

Picture of Xerox Holdings logo

Xerox Holdings

us flag iconNASDAQ Global Select Market

FAQ